# Effects of an antimicrobial peptide on transport- and novel environment-induced stress in British Shorthair cats

**Authors:** Shaohao Chen, Miaomiao Zhang, Haoran Yan, Lan Ye, Qishan Xue, Yuansheng Wu, Kun Zhao, Yizhou Jiang, Qingxin Wang, Jiang Zhu, Yan Guo, Qingshen Liu, Baichuan Deng, Lingna Zhang

PMC · DOI: 10.3389/fvets.2025.1724637 · Frontiers in Veterinary Science · 2026-02-05

## TL;DR

This study shows that feeding cats antimicrobial peptides from yeast helps reduce stress during transportation and in new environments by improving sleep, behavior, and immune function.

## Contribution

The study is the first to demonstrate the stress-reducing effects of dietary antimicrobial peptides in cats through multi-omics analysis.

## Key findings

- AMPs reduced stress scores, escape behaviors, and inflammatory markers in cats during transportation and in new environments.
- AMPs improved antioxidant capacity and modulated gut microbiota, increasing beneficial bacteria like Bacteroides and Prevotella.
- Transcriptomic and metabolomic analyses revealed that AMPs enhanced immune and metabolic pathways, contributing to stress resilience.

## Abstract

Antimicrobial peptides (AMPs) are natural short peptides with known immunomodulatory and anti-inflammatory properties. Their application in feline stress management have not been widely studied. This study aimed to evaluate the effects of dietary AMPs derived from Saccharomyces cerevisiae on cats exposed to transportation and novel environment. Twelve cats were randomly allocated to a control group or a group fed with AMPs. After pre-feeding for 2 weeks, all cats underwent a two-hour transportation and were subsequently housed individually in novel environment for 1 week. Behavioral observations, biochemical assays, gut microbiota analysis, transcriptomics, and metabolomics were performed. AMPs supplementation significantly increased nighttime sleep duration, reduced activity on transportation day, and lowered cat stress scores (CSS) during the first 3 days in the novel environment. In the open field test (OFT), AMPs reduced escape and pacing behaviors (p < 0.05). AMPs also significantly decreased serum levels of CRH, COR, SAA, IL-1β, and IL-6, while increasing IgG and Apo-A1 after recovery. Antioxidant capacity was also significantly improved by AMPs, as shown by the elevated GSH-Px and reduced MDA. Higher abundances of Bacteroides, Prevotella, and Collinsella (p < 0.05), and lower Schaalia (p < 0.05) were observed in the AMP group. Metabolomics revealed that AMPs primarily regulated the nutritional status and immune function of cats by affecting amino acid and lipid metabolism, thereby enhancing their stress resilience. Transcriptomic analysis indicated that AMPs significantly upregulated pathways related to immune function, cell signal transduction, inflammatory response, and lipid metabolism, while downregulating those associated with viral processes. Dietary supplementation of AMPs alleviates stress in cats, potentially by reducing inflammatory and oxidative stress, and modulating gut microbiota, as well as metabolic and immune pathways.

## Linked entities

- **Chemicals:** IL-6 (PubChem CID 165368475), GSH-Px (PubChem CID 168010211), MDA (PubChem CID 1614)
- **Species:** Bacteroides (taxon 816), Prevotella (taxon 838), Collinsella (taxon 102106), Schaalia (taxon 2529408)

## Full-text entities

- **Genes:** CAT [NCBI Gene 101093891], TNF [NCBI Gene 493755], IL-6 [NCBI Gene 493687], CRH [NCBI Gene 692345], IL-10 [NCBI Gene 493683], IFN-gamma [NCBI Gene 493965], TGF-beta [NCBI Gene 768263], Apo-A1 [NCBI Gene 101081076], SAA [NCBI Gene 678660], IL-1beta [NCBI Gene 768274], BDNF [NCBI Gene 493690]
- **Diseases:** infections (MESH:D007239), restlessness (MESH:D011595), endocrine disruptions (MESH:D004700), gastrointestinal dysfunction (MESH:D005767), immune dysfunction (MESH:D007154), tissue damage (MESH:D017695), infectious diseases (MESH:D003141), depression (MESH:D003866), autism (MESH:D001321), anxiety (MESH:D001007), anxious behaviors (MESH:D001523), dysbiosis (MESH:D064806), gut dysfunction (MESH:C535334), pseudomembranous colitis (MESH:D004761), inflammation (MESH:D007249), metabolic diseases (MESH:D008659), dysregulation (MESH:D021081), function (MESH:D003291), carcinogenesis (MESH:D063646), diarrhea (MESH:D003967), BD (MESH:D001528), HPA axis (MESH:D007029)
- **Chemicals:** serine (MESH:D012694), Riboflavin (MESH:D012256), phenylalanine (MESH:D010649), CoA (MESH:D003065), propionate (MESH:D011422), Acetoacetate (MESH:C016635), 2-piperidinone (MESH:C043384), MDA (MESH:D008315), Fatty acid (MESH:D005227), arginine (MESH:D001120), carbohydrates (MESH:D002241), PC (MESH:C053518), dibutyl phthalate (MESH:D003993), butyrate (MESH:D002087), sodium sulfate (MESH:C012036), aspartate (MESH:D001224), leukotriene (MESH:D015289), amino acid (MESH:D000596), tetrahydrocurcumin (MESH:C096277), 3-chlorotyrosine (MESH:C087259), polyunsaturated fatty acids (MESH:D005231), sodium (MESH:D012964), indoxyl sulfate (MESH:D007200), porphobilinogen (MESH:D011162), eicosanoid (MESH:D015777), hippuric acid (MESH:C030514), BCFAs (-), ubiquinone-2 (MESH:C025204), 5-hydroxytryptophol (MESH:C466375), valeric acid (MESH:C038780), Bile acid (MESH:D001647), hypotaurine (MESH:C003949), lipoxins (MESH:D044045), melatonin (MESH:D008550), magnesium (MESH:D008274), glucose (MESH:D005947), ethyl icosapentate (MESH:C035276), 5-HT (MESH:D012701), calcium (MESH:D002118), threonine (MESH:D013912), SCFAs (MESH:D005232), acylglycerol (MESH:D005989), PBS (MESH:D007854), acetate (MESH:D000085), 3,4-dihydro-2H-1-benzopyran-2-one (MESH:C026308), alcohol (MESH:D000438), N-acetyl-L-proline (MESH:C586914), tryptophan (MESH:D014364), lipid (MESH:D008055), cysteine (MESH:D003545), agarose (MESH:D012685), purine (MESH:C030985), Endocannabinoids (MESH:D063388), MTBE (MESH:C043243), ATP (MESH:D000255), pantothenate (MESH:D010205), taurine (MESH:D013654), Butyric acid (MESH:D020148), steroid hormone (MESH:D013256), harmaline (MESH:D006246)
- **Species:** Clostridium (genus) [taxon 1485], Homo sapiens (human, species) [taxon 9606], Clostridioides difficile (species) [taxon 1496], Felis catus (cat, species) [taxon 9685], Collinsella (genus) [taxon 102106], Bacteroides (genus) [taxon 816], Phocea [taxon 1926663], Parabacteroides (genus) [taxon 375288], gut metagenome (species) [taxon 749906], Blautia (genus) [taxon 572511], Dethiosulfovibrio (genus) [taxon 47054], Gallus gallus (bantam, species) [taxon 9031], Paraprevotella (genus) [taxon 577309], Bacillota (clostridial firmicutes, phylum) [taxon 1239], Canis lupus familiaris (dog, subspecies) [taxon 9615], Saccharomyces cerevisiae (baker's yeast, species) [taxon 4932], Prevotella (genus) [taxon 838], Negativibacillus (genus) [taxon 1980693], Mus musculus (house mouse, species) [taxon 10090], Bacillus subtilis (species) [taxon 1423], Megasphaera (genus) [taxon 906], Coriobacteriia (class) [taxon 84998], Actinomycetota (actinobacteria, phylum) [taxon 201174], Collinsella intestinalis (species) [taxon 147207], Schaalia (genus) [taxon 2529408], Actinomyces (genus) [taxon 1654], Sanguibacteroides (genus) [taxon 1635148]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12917902/full.md

## Figures

10 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12917902/full.md

## References

90 references — full list in the complete paper: https://tomesphere.com/paper/PMC12917902/full.md

---
Source: https://tomesphere.com/paper/PMC12917902